A Study to Test the Benefit of a New Anti-cancer Treatment in Patients With Unresectable Advanced Melanoma
Clinical trial NCT00942162 · COMPLETED
Trial details
- NCT number
- NCT00942162
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-14
- Primary completion
- 2012-06-27
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.